Administered as a single injection by subcutaneous or intravenous route at a dose of 6 mg/kg body weight (1 ml/30 kg body weight).
INDICATIONS
Bafloks 180 Solution for Injection is indicated for the treatment of bovine respiratory disease caused by Histophilus somni, Mannheimia haemolytica, and Pasteurella multocida susceptible to danofloxacin, and for the treatment of acute mastitis infections caused by danofloxacin-susceptible Escherichia coli.
It is also used for the treatment of enteric infections caused by danofloxacin-susceptible Escherichia coli in newborn calves.